SwedenLivingWorldBusinessSportsEntertainmentFAQ

EU:s läkemedelsmyndighet

EU Approves Alzheimer's Drug Lecanemab for Sale

The Alzheimer's drug lecanemab has been granted permission by the EU Commission for sale within the union as well as in Iceland, Liechtenstein, and Norway, announces the Swedish company Bioarctic in a press release. The permission is given since EMA, the EU's pharmaceutical authority, approved lecanemab last winter.
EU Approves Alzheimer's Drug Lecanemab for Sale

Not just war: Nine things to look forward to in 2024

2024 was marked by war, misery, and brutal death. But there were glimmers of light.
Not just war: Nine things to look forward to in 2024

Long wait for new Alzheimer's drug

After years of waiting, the message came: the EU's pharmaceutical authority says yes to the drug lecanemab against Alzheimer's. But the question is which patients can be treated, and when – and if it is introduced in the country's regions at all.
Long wait for new Alzheimer's drug

Not just war: Nine things to look forward to in 2024

2024 was marked by war, misery, and brutal death. But there were glimmers of light.
Not just war: Nine things to look forward to in 2024

EMA's turnaround: Approves Alzheimer's drug

The disappointment was great when a new Alzheimer's drug was rejected by the EU's pharmaceutical authority (EMA) last summer. But now EMA has reconsidered its statement – and approves the sale of the drug lecanemab for the treatment of certain Alzheimer's patients.
EMA's turnaround: Approves Alzheimer's drug
Show Consent Options

Categories

Information

Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald